+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Type 2 Diabetes Market and Competitive Landscape - 2020

  • ID: 5023466
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Type 2 Diabetes Market and Competitive Landscape - 2020, provides comprehensive insights into the Type 2 Diabetes pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Type 2 Diabetes market size and drug sales. It also provides insights into Type 2 Diabetes epidemiology and late stage pipeline.

This research covers the following: Type 2 Diabetes treatment options, Type 2 Diabetes late stage clinical trials pipeline, Type 2 Diabetes prevalence by countries, Type 2 Diabetes market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Type 2 Diabetes pipeline: Find out drugs in clinical trials for the treatment of Type 2 Diabetes by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Type 2 Diabetes epidemiology: Find out the number of patients diagnosed (prevalence) with Type 2 Diabetes by countries
  • Type 2 Diabetes drugs: Identify key drugs marketed and prescribed for Type 2 Diabetes in the US, including trade name, molecule name, and company
  • Type 2 Diabetes drugs sales: Find out the sales value for Type 2 Diabetes drugs by countries
  • Type 2 Diabetes market valuations: Find out the market size for Type 2 Diabetes drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Type 2 Diabetes drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Type 2 Diabetes drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Type 2 Diabetes market
  • Develop in-depth knowledge of competition and markets
  • Analyze Type 2 Diabetes drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Type 2 Diabetes market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Type 2 Diabetes Treatment Options

2. Type 2 Diabetes Pipeline Insights
2.1. Type 2 Diabetes Phase 3 Clinical Trials
2.2. Type 2 Diabetes Phase 2 Clinical Trials
2.3. Type 2 Diabetes Phase 1 Clinical Trials

3. Type 2 Diabetes Epidemiology Analysis by Countries

4. Germany Type 2 Diabetes Market Insights
4.1. Marketed Drugs for Type 2 Diabetes in Germany
4.2. Germany Type 2 Diabetes Market Size & Forecast
4.3. Germany Type 2 Diabetes Drugs Sales Forecast
4.4. Germany Type 2 Diabetes Market Share Analysis

5. France Type 2 Diabetes Market Insights
5.1. Marketed Drugs for Type 2 Diabetes in France
5.2. France Type 2 Diabetes Market Size & Forecast
5.3. France Type 2 Diabetes Product Sales Forecast
5.4. France Type 2 Diabetes Market Share Analysis

6. Italy Type 2 Diabetes Market Insights
6.1. Marketed Drugs for Type 2 Diabetes in Italy
6.2. Italy Type 2 Diabetes Market Size & Forecast
6.3. Italy Type 2 Diabetes Product Sales Forecast
6.4. Italy Type 2 Diabetes Market Share Analysis

7. Spain Type 2 Diabetes Market Insights
7.1. Marketed Drugs for Type 2 Diabetes in Spain
7.2. Spain Type 2 Diabetes Market Size & Forecast
7.3. Spain Type 2 Diabetes Product Sales Forecast
7.4. Spain Type 2 Diabetes Market Share Analysis

8. UK Type 2 Diabetes Market Insights
8.1. Marketed Drugs for Type 2 Diabetes in UK
8.2. UK Type 2 Diabetes Market Size & Forecast
8.3. UK Type 2 Diabetes Product Sales Forecast
8.4. UK Type 2 Diabetes Market Share Analysis

9. Europe Type 2 Diabetes Market Insights
9.1. Europe Type 2 Diabetes Market Size & Forecast
9.2. Europe Type 2 Diabetes Product Sales Forecast
9.3. Europe Type 2 Diabetes Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Type 2 Diabetes Phase 3 Clinical Trials, Global, 2020
Table 2: Type 2 Diabetes Phase 2 Clinical Trials, Global, 2020
Table 3: Type 2 Diabetes Phase 1 Clinical Trials, Global, 2020
Table 4: Type 2 Diabetes Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Type 2 Diabetes in Germany, 2019
Table 6: Germany Type 2 Diabetes Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Table 8: Germany Type 2 Diabetes Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Type 2 Diabetes in France, 2019
Table 10: France Type 2 Diabetes Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Table 12: France Type 2 Diabetes Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Type 2 Diabetes in Italy, 2019
Table 14: Italy Type 2 Diabetes Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Table 16: Italy Type 2 Diabetes Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Type 2 Diabetes in Spain, 2019
Table 18: Spain Type 2 Diabetes Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Table 20: Spain Type 2 Diabetes Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Type 2 Diabetes in UK, 2019
Table 22: UK Type 2 Diabetes Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Table 24: UK Type 2 Diabetes Market Events and Trends, 2016 - 2024
Table 25: Europe Type 2 Diabetes Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Type 2 Diabetes Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Type 2 Diabetes Pipeline by Phase (%), Global, 2020
Figure 2: Type 2 Diabetes Prevalence by Countries, 2016 - 2024
Figure 3: Germany Type 2 Diabetes Market Size ($mn), 2016 - 2024
Figure 4: Germany Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Figure 5: Germany Type 2 Diabetes Market Share by Drugs (%), 2019
Figure 6: Germany Type 2 Diabetes Market - Future Market Share (%), 2024
Figure 7: France Type 2 Diabetes Market Size ($mn), 2016 - 2024
Figure 8: France Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Figure 9: France Type 2 Diabetes Market Share by Drugs (%), 2019
Figure 10: France Type 2 Diabetes Market - Future Market Share (%), 2024
Figure 11: Italy Type 2 Diabetes Market Size ($mn), 2016 - 2024
Figure 12: Italy Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Figure 13: Italy Type 2 Diabetes Market Share by Drugs (%), 2019
Figure 14: Italy Type 2 Diabetes Market - Future Market Share (%), 2024
Figure 15: Spain Type 2 Diabetes Market Size ($mn), 2016 - 2024
Figure 16: Spain Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Figure 17: Spain Type 2 Diabetes Market Share by Drugs (%), 2019
Figure 18: Spain Type 2 Diabetes Market - Future Market Share (%), 2024
Figure 19: UK Type 2 Diabetes Market Size ($mn), 2016 - 2024
Figure 20: UK Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Figure 21: UK Type 2 Diabetes Market Share by Drugs (%), 2019
Figure 22: UK Type 2 Diabetes Market - Future Market Share (%), 2024
Figure 23: Europe Type 2 Diabetes Market Size ($mn), 2016 - 2024
Figure 24: Europe Type 2 Diabetes Product Sales ($mn), 2016 - 2024
Figure 25: Europe Type 2 Diabetes Market Share by Drugs (%), 2019
Figure 26: Europe Type 2 Diabetes Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll